GE HealthCare

Company Overview

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions company. On January 4, 2023, GE HealthCare spun off from General Electric Co. and began operating as an independent company. GE HealthCare has a presence in more than 160 countries and serves more than one billion patients a year. The company operates into four segments: Imaging, Ultrasound, Patient Care Solutions (PCS) and Pharmaceutical Diagnostics (PDx).

The PDx segment is comprised of two business lines: Contrast Media and Molecular Imaging or Radiopharmaceuticals. GE HealthCare is a leading supplier of radiopharmaceuticals and cold kits for the compounding of radiopharmaceuticals globally. The company manufactures these products in three CGMP-certified molecular imaging production facilities and operates 31 nuclear pharmacies in the U.S.

Financial Highlights (FY 2024)

Company's Business Segments

• Imaging : Molecular Imaging, Computed Tomography, Magnetic Resonance, Image-Guided Therapies, Women’s Health, and X-ray
• Advanced Visualization Solutions (AVS) : CardioVascular and Interventional Solutions, Comprehensive Care Ultrasound, Women’s Health Ultrasound, Surgical Innovations products.
• Patient Care Solutions (PCS) : Patient Monitoring, Anesthesia Delivery and Respiratory Care, Diagnostic Cardiology, Maternal Infant Care, and Consumables and Services connected by and differentiated with their digital solutions
• Pharmaceutical Diagnostics (SPDx) : Contrast Media and Molecular Imaging